Home LiteratureArticle Details
PMID: 2649413 Published · ppublish English Clinical Trial Comparative Study Journal Article Randomized Controlled Trial

Acid induced duodenal ulcer pain: the influence of symptom status and the effect of an antispasmodic.

Gut ·Vol. 30 ·No. 2 ·1989-02-00 ·Pages 166-70

Kang JY, Yap I, Guan R, Tay HH, Math MV

Abstract

The aims of this study were to determine whether the development of acid induced duodenal ulcer pain was influenced by the symptomatic status of the patient and whether the administration of an antispasmodic could abolish pain. One hundred millilitres of 0.1 N hydrochloric acid was infused onto the ulcer craters or scars of 143 duodenal ulcer patients on 168 occasions. Symptomatic patients were randomised to receive 40 mg of hyoscine intravenously before acid infusion, or to a control group. Typical ulcer pain developed in seven of 55 (13%) instances for non-symptomatic patients, 24/57 (42%) of control symptomatic patients, and 20/56 (36%) of symptomatic patients given hyoscine. (Asymptomatic group v control symptomatic group, p less than 0.005; control symptomatic group v hyoscine group, NS - 95% confidence limits 12% in favour of the control and 24% in favour of the hyoscine group). The results suggest that acid infusion seldom reproduces ulcer pain in non-symptomatic duodenal ulcer patients and that the pathogenesis of acid induced duodenal ulcer pain probably involves a mechanism other than spasm, as pain was not prevented by an anticholinergic.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Clinical Trials as Topic Double-Blind Method Duodenal Ulcer/pathology,physiopathology Duodenoscopy Female Gastroscopy Humans Hydrochloric Acid/pharmacology Male Middle Aged Pain/etiology,prevention & control Scopolamine/therapeutic use
Chemicals
Scopolamine Hydrochloric Acid
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Kang J Y
University Department of Medicine, National University of Singapore.
Yap I
Guan R
Tay H H
Math M V
References (12)
12 references, click to expand
  1. Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial.
    Gut. 1979 Jan;20(1):68-74 PMID: 367885
  2. Most patients with active symptomatic duodenal ulcers fail to develop ulcer-type pain in response to gastroduodenal acidification.
    J Clin Gastroenterol. 1982 Apr;4(2):105-8 PMID: 7086102
  3. Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study.
    Gut. 1986 Aug;27(8):942-5 PMID: 3732901
  4. Reproduction of epigastric pain of duodenal ulceration by adenosine.
    Br Med J (Clin Res Ed). 1987 Jan 3;294(6563):10-2 PMID: 3101777
  5. Further observations on the mechanism of ulcer pain.
    Ann Intern Med. 1959 Dec;51:1275-94 PMID: 13837632
  6. Duodenitis.
    Clin Gastroenterol. 1978 Sep;7(3):635-50 PMID: 361306
  7. Letter: Confidence limits in evaluating controlled therapeutic trials.
    Lancet. 1973 Oct 27;2(7835):969-70 PMID: 4126592
  8. Epigastric pain in duodenal ulcer.
    Br Med J. 1975 May 3;2(5965):254-5 PMID: 1167251
  9. Histamine H2-receptor antagonists in the treatment of duodenal ulcers.
    S Afr Med J. 1976 Oct 16;50(44):1781-5 PMID: 11564
  10. Healing of duodenal ulcer with an antacid regimen.
    N Engl J Med. 1977 Aug 18;297(7):341-5 PMID: 876324
  11. Peptic ulceration and its correlation with symptoms.
    Clin Gastroenterol. 1978 Sep;7(3):571-82 PMID: 361302
  12. Further experience with epigastric pain reproduction test in duodenal ulceration.
    Br Med J. 1972 Jun 17;2(5815):683-5 PMID: 5031711
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
1989-02-00
Pages
166-70
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1378296
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]